Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12814842 | 0.84 | KEAP1 (0.32) | KEAP1NFE2L2CHRM2CYP2D6CHRM1 | |
| SCHEMBL12815272 | 0.82 | NPC1 (0.35) | — | |
| SCHEMBL12814771 | 0.81 | KEAP1 (0.30) | KEAP1NFE2L2CHRM2CYP2D6CHRM1 | |
| Hydrochloric Acid SCHEMBL16457937 | 0.78 | — | — | |
| SCHEMBL16459345 | 0.76 | CHRM2 (0.34) | CHRM2CYP2D6CHRM1KCNH2 | |
| SCHEMBL12815044 | 0.67 | MEN1 (0.30) | CYP2D6 | |
| SCHEMBL12815692 | 0.67 | GAA (0.38) | CHRM2CHRM1 | |
| SCHEMBL12815062 | 0.67 | — | — | |
| SCHEMBL10319313 | 0.67 | — | — | |
| Phenol SCHEMBL5273286 | 0.66 | CA12 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140012056-A1 | METHOD FOR PRODUCING 1-HEXENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012056-A1 | METHOD FOR PRODUCING 1-HEXENE | AP2A1, AP1M1, ME1 | KEAP1 1392/4885NFE2L2 257/4885CHRM2 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.